CHIEF MEDICAL OFFICER · KalVista Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$60K
Shares
2,239
Price
$26.78
Executed
May 26, 2026
Disclosed
May 27, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
May 26 executedMay 27, 2026 disclosed
KALV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Audhya Paul K. filed this Form 4 reporting a open-market sale of KALV on May 26, 2026. It became public on May 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CHIEF MEDICAL OFFICER
Audhya Paul K.cik:0001860131
Issuer
KalVista Pharmaceuticals, Inc.cik:0001348911
Revision history · 0
No field has changed since this record was first ingested.
